Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Fernandez-Fernandez, B; Fernandez-Prado, R; Gorriz, JL; Martinez-Castelao, A; Navarro-Gonzalez, JF; Porrini, E; Soler, MJ; Ortiz, A

Ortiz, A (reprint author), Fdn Jimenez Diaz UAM, IIS, Madrid, Spain.; Ortiz, A (reprint author), UAM, Sch Med, Madrid, Spain.; Ortiz, A (reprint author), REDINREN, Madrid, Spain.; Ortiz, A (reprint author), GEENDIAB, Barcelona, Spain.

CLINICAL KIDNEY JOURNAL, 2019; 12 (3): 313

Abstract

In April 2019, two major Phase 3 randomized clinical trials were published that assessed primary renal outcomes in diabetic kidney disease (DKD) in ty......

Full Text Link